HDAC9 and glioblastoma: Based on this hypothesis, we evaluated the cytotoxic effect of simultaneous inhibition of glycolysis and HDAC activity, two upregulated pathways driving GBM growth, using 2-DG or WP1122 with sodium valproate (NaVPA) or NaBt.